| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/08/2005 | US20050196830 Amino acid modified polypeptides |
| 09/08/2005 | US20050196816 Monoclonal antibodies for binding immunoglobins |
| 09/08/2005 | US20050196802 peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily; use drug screening |
| 09/08/2005 | US20050196797 PI-3-kinase-related kinase polypeptide for use as tool in identifying modulators for prevntion and treatment of cell proliferation disorders |
| 09/08/2005 | US20050196788 isolated bacterial oxidase, comprising an oxidase that regenerates NADP+, NAD+, or both; isolated from Lactobacillus |
| 09/08/2005 | US20050196777 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 09/08/2005 | US20050196406 Which display a passenger polypeptide on the outer surface of a biological entity; displayed passenger polypeptide is capable of interacting or binding with a given ligand |
| 09/08/2005 | US20050196405 Pneumococcal surface protein c (pspc), epitopic regions and strain selection thereof, and uses therefor |
| 09/08/2005 | US20050196402 Immunoglobulin constant region modified to reduce mediated biological effector function relative to a CTLA4-IgG1 fusion protein; nucleic acids integrated into expression vectors direct synthesis of corresponding proteins in a variety of hosts; inhibit transplantation rejection, graft versus host disease |
| 09/08/2005 | US20050196398 Nucleotide sequences coding specialized hydrolase for use as tool in identifying modulator for prevention and treatment of nervous system disorders; enzyme inhibitors |
| 09/08/2005 | US20050196388 Lactic acid bacterial culture for obtaining fermented dairy products from milk supplemented with glucose; fermenting yogurt |
| 09/08/2005 | DE102004017793A1 Use of trioxacarcins for treatment and prevention of infectious diseases, also new trioxacarcins for treatment of e.g. tumors, inflammatory and autoimmune diseases |
| 09/07/2005 | EP1571448A1 Fluorescent indicator using fret |
| 09/07/2005 | EP1571223A2 L-cysteine-producing microorganism and a method for producing L-cysteine |
| 09/07/2005 | EP1571217A1 Increasing production of proteins in gram-positive microorganisms |
| 09/07/2005 | EP1571216A2 Phosphodiesterase 8A |
| 09/07/2005 | EP1571214A2 Immunogenic detoxified mutant toxin |
| 09/07/2005 | EP1571213A1 Bifidobacterium longum AR81 (KCCM-10492) enabling inhibition of rotavirus and active protein separated therefrom |
| 09/07/2005 | EP1571211A1 Antibodies against lesion tissue |
| 09/07/2005 | EP1571207A1 Novel cellulase tolerant to surfactants |
| 09/07/2005 | EP1571203A2 Anti-inflammatory active principles in Euganean thermal mud |
| 09/07/2005 | EP1571202A1 PVA-decomposing bacteria and method for decomposing PVA |
| 09/07/2005 | EP1571199A2 Multiply-substituted protease variants |
| 09/07/2005 | EP1570063A1 New expression system from rhodococcus |
| 09/07/2005 | EP1570050A1 Bacterial strains of genus exiguobacterium, culture method and uses |
| 09/07/2005 | EP1570049A1 Microorganism producing 5 xanthylic acid |
| 09/07/2005 | EP1570048A2 Biological control agent and formulations |
| 09/07/2005 | EP1570047A2 Composition and method for inhibition of microorganisms |
| 09/07/2005 | EP1570046A1 Method and device for drying of micro-organisms |
| 09/07/2005 | EP1569674A2 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide |
| 09/07/2005 | EP1569509A1 Cryogenically protected viral delivery systems and related manufacture and use |
| 09/07/2005 | EP1025207B1 Suspension packing cell lines for retrovirus vectors |
| 09/07/2005 | CN1665931A Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 09/07/2005 | CN1665930A Expression systems for stem loop RNA molecule having RNAi effect |
| 09/07/2005 | CN1665925A Factor VII or VIIa polypeptide variants |
| 09/07/2005 | CN1665923A Mpg added to fermentation |
| 09/07/2005 | CN1665922A Medium for culturing autologous human progenitor stem cells and applications thereof |
| 09/07/2005 | CN1665919A Zymomonas pentose-sugar fermenting strains and uses thereof |
| 09/07/2005 | CN1665833A Novel variants of the PapM polypeptide of bacteria of genus streptomyces |
| 09/07/2005 | CN1665799A Motilide compounds |
| 09/07/2005 | CN1665543A Fusions of cytokines and tumor targeting proteins |
| 09/07/2005 | CN1664107A DNA sequence coding for an a. thaliana protein with delta-5, 7-sterol-delta-7-reductase, the protein, process for the production, transformed yeast-strains and use |
| 09/07/2005 | CN1664106A Generation of L-glutamic acid bacterium and process for producing L-glutamic acid |
| 09/07/2005 | CN1664097A Expression of Hypoderm A (HA) in pastoris system and use thereof |
| 09/07/2005 | CN1664094A Pathogenic bacteria of gummy stem blight of melon, induction method for its conidiophore and use thereof |
| 09/07/2005 | CN1664093A Spiral algae with high content of taurine and method for producing same |
| 09/07/2005 | CN1663963A Hybrid interferon compositions and methods of use |
| 09/07/2005 | CN1663573A A stable and safe microecological formulation, its preparation and usage |
| 09/07/2005 | CN1663425A Method for fermenting solid-state aquatic plant by microbe to produce protein feedstuff |
| 09/07/2005 | CN1663394A Wireworm-killing biologic bacterial agent, its preparation and application |
| 09/07/2005 | CN1218182C Method for separating cells using immunorosettes |
| 09/07/2005 | CN1218037C Chlamydospores and process for producing same |
| 09/07/2005 | CN1218036C Mucor mould for production of preserved beancurd |
| 09/07/2005 | CN1218035C Culture of long chain unsaturated fatty acid by heterotrophic marine microalgal |
| 09/07/2005 | CN1217570C Agaric pilose mixed fungus fermentation culturing method and its culturing medium |
| 09/06/2005 | US6939959 Efficient protein expression system |
| 09/06/2005 | US6939956 Variable region of the monoclonal antibody against HBV S-surface antigen and a gene encoding the same |
| 09/06/2005 | US6939949 Protein for use in diagnosis and treatment of cancer |
| 09/06/2005 | US6939708 Method of rapid bio-cycling of an aquarium |
| 09/06/2005 | US6939706 Decomposing polyester; obtain polyester degrading microorganism, incubate with polyester, monitor decomposing polyester |
| 09/06/2005 | US6939705 treating lactobacillus (L. johnsonii La1) with sodium chloride and heating; comprises Bifidobacterium |
| 09/06/2005 | US6939704 Enhanced expression of proteins in genetically modified fungi |
| 09/06/2005 | US6939703 Amylolytic enzymes derived from the B.licheniformis α-amylase, having improved characteristics |
| 09/06/2005 | US6939699 A heat-stable enzyme having a DNA helicase activity, and a structure-specific endonuclease activity; obtained by cloning a gene encoding the enzyme from chromosomal DNA of a a sulfur-metabolizing thermophilic archaebacteria |
| 09/06/2005 | US6939696 Cell disruption method using sonication |
| 09/06/2005 | US6939688 comprises Azotobacter chroococcum and Beijerinckia fluminensis nitrogen binding bacteria, and another comibination of Bacillus megaterium and Bacillus mucilaginosis, which decompose phosphorus and potassium compounds |
| 09/06/2005 | US6939680 Nucleotide sequences coding protein for use in the treatment and prevention of nervous system, dyskinesia, kidney, vascular, circadian rhythms and vision defects |
| 09/06/2005 | US6939533 Non-invasive localization of a light-emitting conjugate in a mammal |
| 09/06/2005 | CA2261041C Bacillus thuringiensis strains showing improved production of certain lepidopteran-toxic crystal proteins |
| 09/01/2005 | WO2005080604A2 Genetic analysis by sequence-specific sorting |
| 09/01/2005 | WO2005080575A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
| 09/01/2005 | WO2005080572A1 Triterpene hydroxylase |
| 09/01/2005 | WO2005080550A1 Lactic acid with high nisin-productivity and method of selecting the same |
| 09/01/2005 | WO2005080549A2 Trioxacarcins and their use against infections |
| 09/01/2005 | WO2005080548A1 Frozen lactic acid bacteria culture of individual pellets |
| 09/01/2005 | WO2005080420A2 Hyphal growth in fungi |
| 09/01/2005 | WO2005079580A1 Pland disease controlling composition and microorganism |
| 09/01/2005 | WO2005079367A2 Schizochytrium fatty acid synthase (fas) and products and methods related thereto |
| 09/01/2005 | WO2005079276A2 Selective growth medium for listeria spp |
| 09/01/2005 | WO2005056786A3 Sugar kinases with expanded substrate specificity and their use |
| 09/01/2005 | WO2005052191A8 Compositions and methods for the diagnosis and treatment of tumor |
| 09/01/2005 | WO2005001024A3 Genes encoding carotenoid compounds |
| 09/01/2005 | WO2004101746A3 Production of carotenoids in microorganisms |
| 09/01/2005 | WO2004048512A3 Novel proteins and nucleic acids encoding same |
| 09/01/2005 | WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases |
| 09/01/2005 | WO2003018759A3 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same |
| 09/01/2005 | WO2003013426A3 Multivalent synthetic vaccine for cancer |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050191741 Microbial composition and a process useful for the neutralization of alkaline waste- waters |
| 09/01/2005 | US20050191738 Modified reductase and its gene, and use thereof |
| 09/01/2005 | US20050191736 Polypeptides having cellulolytic enhancing activity andpolynucleotides encoding same |
| 09/01/2005 | US20050191735 Oxidoreductase |
| 09/01/2005 | US20050191733 Nucleotide sequences coding glucose transport protein for use in enhancement of foods, cosmetic and animal feeds |
| 09/01/2005 | US20050191732 Vector comprising nucleotide sequences coding homeostasis and adaptation (HA) proteins for use in enhancing/improving heterologous gene expression |
| 09/01/2005 | US20050191728 Connecting peptides (mini C-peptides) which confer an increased production yield in insulin derivatives when expressed in a transformed microorganism |
| 09/01/2005 | US20050191727 Modified viral sequences which enhance genic expression in microorganismal host |
| 09/01/2005 | US20050191723 Improving gene expression in host cells vial use of vector comprising stabilizing anti-repressor (STAR) sequences; enhancer elements |
| 09/01/2005 | US20050191720 A vector for the surface expression of antibiotics composed of one or more genes that encode the synthetase and a gene encoding an amphiphilic peptide antibiotic having antibacterial, antifungal and anticancer activities; lactic acid-forming bacteria transformed with the vector |
| 09/01/2005 | US20050191703 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides |
| 09/01/2005 | US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |